|
ZNF808 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.378600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.430900E-04 |
| Normal-vs-Stage2 |
2.489000E-01 |
| Normal-vs-Stage3 |
5.60640000000223E-05 |
| Normal-vs-Stage4 |
7.205500E-04 |
| Stage1-vs-Stage2 |
5.914800E-01 |
| Stage1-vs-Stage3 |
8.616100E-02 |
| Stage1-vs-Stage4 |
1.342000E-01 |
| Stage2-vs-Stage3 |
1.864240E-01 |
| Stage2-vs-Stage4 |
1.440640E-01 |
| Stage3-vs-Stage4 |
7.088000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.800600E-04 |
| Normal-vs-AfricanAmerican |
2.615600E-02 |
| Normal-vs-Asian |
1.88329996042569E-09 |
| Caucasian-vs-AfricanAmerican |
2.913200E-01 |
| Caucasian-vs-Asian |
4.61379999761036E-08 |
| AfricanAmerican-vs-Asian |
4.7088000000306E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.573200E-04 |
| Normal-vs-Female |
2.085700E-02 |
| Male-vs-Female |
3.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.182560E-03 |
| Normal-vs-Extreme_Weight |
6.3159999999951E-05 |
| Normal-vs-Obese |
2.451900E-02 |
| Normal-vs-Extreme_Obese |
1.626850E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.084800E-01 |
| Normal_Weight-vs-Obese |
3.524200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.563000E-01 |
| Extreme_Weight-vs-Obese |
1.053360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.633200E-01 |
| Obese-vs-Extreme_Obese |
9.127200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.148300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.958900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.739820E-03 |
| Normal-vs-Age(81-100Yrs) |
3.556100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.116000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.492400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.113000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.493200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.904400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.921030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.488100E-02 |
| Normal-VS-Type2 PRCC |
8.11229999841956E-08 |
| Normal-VS-KIRP CIMP |
1.988830E-04 |
| Normal-VS-Unclassified PRCC |
4.785700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.51510000000665E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.876020E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.979800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.232400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.623600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.240100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.65060000004258E-06 |
| Normal-vs-N1 |
9.85420000000348E-05 |
| Normal-vs-N2 |
1.115380E-03 |
| N0-vs-N1 |
7.536200E-01 |
| N0-vs-N2 |
8.447700E-02 |
| N1-vs-N2 |
1.420370E-01 |
|
|
